13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • PURPLE

    Acronym: 

    PURPLE

    ACTRN/NCT /ethics: 

    ACTRN12617001474347

    Scientific title: 

    Pancreatic cancer: Understanding routine practice and lifting end results (Purple). A prospective pancreatic cancer clinical registry.

    Summary of trial and patient characteristics

    Cancer Type Pancreas
    Trial Type Early detection, diagnosis, prognosis
    Phase Tumour Stream Pancreas
    Age Range 18 years and older Cancer Stage All stages
    Sex Both Anticipated Start Date 2017-02-15
    Molecular Target Anticipated End Date 2020-07-31
    Cancer Type Pancreas
    Trial Type Early detection, diagnosis, prognosis
    Phase
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Pancreas
    Cancer Stage All stages
    Anticipated Start Date 2017-02-15
    Anticipated End Date 2020-07-31

    Trial Summary

    This project is non-interventional registry of the treatment and outcomes of patients with pancreatic cancer managed at hospitals enrolled to participate in Australia. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been newly diagnosed with pancreatic cancer (with or without metastatic disease) , with any ECOG performance status and are yet to receive treatment. Study details This registry will capture data on presentation and the disease course of pancreatic cancer, surgical interventions for primary and metastatic disease, prescription of systemic therapies, and information regarding multi-disciplinary management and outcomes of this disease in the routine clinical practice setting. This project will collect clinical data using the already established data collection and analysis resources built up over the last 15 years in the Systems Biology & Personalised Medicine Division of the Walter & Eliza Hall Institute of medical research (WEHI). This protocol aims to enrol at least 800 eligible patients over 10 years. Findings from analyses that occur as part of this project are anticipated to improve our understanding of the presentation, clinical course and management of pancreatic cancer in Australia and other participating countries.

    Lay Summary

    Pancreatic cancer: Understanding routine practice and lifting end results (Purple). A prospective pancreatic cancer clinical registry.

    Sponsor / Cooperative group

    Walter & Eliza Hall Institute

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Amitesh Roy Recruiting